Clinical Trial Update: Assessing 11C-Choline (11C-CH) PET to Distinguish True Tumor Progression From Pseudoprogression in High-grade Gliomas [NA]

View source ↗

Summary

Clinical trial investigating 11C-Choline PET to distinguish true tumor progression from pseudoprogression in high-grade gliomas has completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• High-grade Glioma

Drugs mentioned

• [11C]Choline (Carbon-11 labeled choline radiotracer)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Cancer | NA | Status: COMPLETED | Results posted: 2022-12-29